CVS Health Payor Solutions
Payor Solutions
Main menu
Biosimilars
About
Our Story
Who We Serve
Integrated Assets
Insights
All Insights
Care Management
Cost Management
Drug Pipeline
Government Programs & Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Contributors
Programs & Services
Overview
Cost Management
Formulary Management
Network Strategies
Hyperinflation
Gene Therapy Solutions
Member Affordability
Specialty Management
Specialty Cost Management
Medical Benefit Solutions
Transform Oncology Care
Patient Care
Radiation Oncology
Care Management
Member Engagement
Onboarding
Benefit Plan Changes
Health Plan Client Engagement
Shortcuts
Contact Us
Resources
Videos
News
Webinars
Events
Other Sites
Client Care Access
CVS Health
CVS Caremark
CVS Specialty
CVS Pharmacy
CVS MinuteClinic
Search form
Search
“Pipeline”
47 result(s)
Format
All Formats
Briefing
Commentary
Feature
Infographic
Specialty Report
Video
White Paper
Sort by
Most Recent
Most Popular
Drug Pipeline
Non-Alcoholic Steatohepatitis on the Rise Around the World
Non-Alcoholic Steatohepatitis on the Rise Around the World
More
Briefing
Cost Management
Keeping medications affordable for members
Keeping medications affordable for members
More
Briefing
Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline
More
Briefing
Drug Pipeline
Managing New Drug Options for Obesity
...
More
Briefing
Drug Pipeline
Optimizing Treatment for Inflammatory Bowel Disease
New Drugs and Tools to Optimize IBD Treatment
More
Briefing
Drug Pipeline
Advances in Delivering Gene Therapies
The different types of gene therapy and how they work
More
Briefing
Drug Pipeline
Promising Treatments for Alopecia Areata in the Pipeline
New Treatments for Alopecia Areata on the Horizon
More
Briefing
Specialty
Managing the MS Cost Challenge
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment...
More
Briefing
Drug Pipeline
Keeping an Eye on the Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon
More
Briefing
Health Equity
Marketplace Trends Shape Specialty Landscape
...
More
Briefing
Load More